Tag: ivantis

Commercial & Investment Banking Picture Gallery

Ivantis Raises $25 Million Series C to Fund Future US Commercialization of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS)

January 9, 2017
Presse

IRVINE, CA — (Marketwired) — 01/09/17 — , developer of the novel Hydrus Microstent device designed…

Continue Reading